Literature DB >> 34372864

Postpartum Green Star family planning decision aid for pregnant adolescents in Tanzania: a qualitative feasibility study.

Stella E Mushy1, Eri Shishido2, Sebalda Leshabari3, Shigeko Horiuchi2.   

Abstract

BACKGROUND: The use of a decision aid in clinical settings has been beneficial. It informs and educates patients about the available treatment options that can help them reduce decision-making conflicts related to feeling uninformed compared with routine care. There is a scarcity of published data about using a decision aid during family planning counseling with postpartum women focusing on long-acting reversible contraception in Tanzania. Therefore, we developed a "postpartum Green Star family planning decision aid" and assessed its feasibility. The study outcomes were practicality, usefulness, and acceptability perceived by pregnant adolescents and nurses/midwives.
METHODS: We used an exploratory qualitative in-depth interview involving six nurses/midwives with three or more years of experience in family planning services and 12 pregnant adolescents aged 15-19 years. Purposive sampling was used to select the participants, and selection relied on the saturation principle of data collection. We used a semi-structured interview guide translated into the Kiswahili language. Data were transcribed and analyzed following inductive content analysis.
RESULTS: The amount of information presented was just right, with the time of reading the data ranging from 20 min to 1 h. The study participants perceived the flow of information to be good, with small significant changes suggested. Kiswahili language was used and reported to be appropriate and well elaborated. However, a few words were told to be rephrased to reduce ambiguity. The nurses/midwives said that the decision aid included most of the vital information the participants wanted to know during their family planning counseling. Pregnant adolescents stated that the decision aid improved their knowledge and provided new details on the long-acting reversible contraception methods (intrauterine copper devices and implants) offered immediately after childbirth. The participants stated that the decision aid addressed long-acting reversible contraception methods' benefits and side effects and dispelled myths and misconceptions. The study participants considered the decision aid helpful in complementing the family planning counseling offered and improving pregnant adolescents' knowledge.
CONCLUSION: The postpartum Green Star family planning decision aid was practical, useful, and acceptable in enhancing the objectivity of counseling about long-acting reversible contraception methods. It improved the knowledge of pregnant adolescents in Tanzania about the available contraception methods (i.e., the use of intrauterine copper devices and implants), which can be immediately used postpartum. Further research is needed to assess the effects of the decision aid on long-acting reversible contraception postpartum uptake among pregnant adolescents in Tanzania.
© 2021. The Author(s).

Entities:  

Keywords:  Adolescent mothers; Decision aid; Implants; Intrauterine copper device; Long-acting reversible contraception; Postpartum family planning; Pregnant adolescents; Rapid repeat pregnancy; Tanzania

Year:  2021        PMID: 34372864     DOI: 10.1186/s12978-021-01216-6

Source DB:  PubMed          Journal:  Reprod Health        ISSN: 1742-4755            Impact factor:   3.223


  16 in total

1.  Childbearing in adolescents aged 12-15 years in low resource countries: a neglected issue. New estimates from demographic and household surveys in 42 countries.

Authors:  Sarah Neal; Zoë Matthews; Melanie Frost; Helga Fogstad; Alma V Camacho; Laura Laski
Journal:  Acta Obstet Gynecol Scand       Date:  2012-07-12       Impact factor: 3.636

Review 2.  The effect of long-acting reversible contraception on rapid repeat pregnancy in adolescents: a review.

Authors:  Maureen K Baldwin; Alison B Edelman
Journal:  J Adolesc Health       Date:  2013-04       Impact factor: 5.012

Review 3.  Interventions for improving coverage of childhood immunisation in low- and middle-income countries.

Authors:  Angela Oyo-Ita; Charles S Wiysonge; Chioma Oringanje; Chukwuemeka E Nwachukwu; Olabisi Oduwole; Martin M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2016-07-10

4.  Effect of a decision aid with patient narratives in reducing decisional conflict in choice for surgery among early-stage breast cancer patients: A three-arm randomized controlled trial.

Authors:  Wakako Osaka; Kazuhiro Nakayama
Journal:  Patient Educ Couns       Date:  2016-09-20

5.  Barriers to the uptake of modern family planning methods among female youth of Temeke District in Dar es Salaam, Tanzania: A qualitative study.

Authors:  Stella E Mushy; Edith A M Tarimo; Agnes Fredrick Massae; Shigeko Horiuchi
Journal:  Sex Reprod Healthc       Date:  2020-02-03

6.  Update in pediatric dentistry.

Authors:  K F Jones; J H Berg; D Coody
Journal:  J Pediatr Health Care       Date:  1994 Jul-Aug       Impact factor: 1.812

7.  Patients' perspectives on sexual history taking in Korea.

Authors:  Su Hyun Kim; Young-Mee Lee; Jong Tae Park
Journal:  Patient Educ Couns       Date:  2007-12-20

8.  Effect of a decision aid on the choice of pregnant women whether to have epidural anesthesia or not during labor.

Authors:  Eri Shishido; Wakako Osaka; Ayame Henna; Yuko Motomura; Shigeko Horiuchi
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

9.  Determinants and consequences of short birth interval in rural Bangladesh: a cross-sectional study.

Authors:  Hendrik C C de Jonge; Kishwar Azad; Nadine Seward; Abdul Kuddus; Sanjit Shaha; James Beard; Anthony Costello; Tanja A J Houweling; Ed Fottrell
Journal:  BMC Pregnancy Childbirth       Date:  2014-12-24       Impact factor: 3.007

10.  Supplementing factual information with patient narratives in the cancer screening context: a qualitative study of acceptability and preferences.

Authors:  Kirsty F Bennett; Christian von Wagner; Kathryn A Robb
Journal:  Health Expect       Date:  2015-03-01       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.